ISRAEL: New medical cannabis company Yom Chai has entered into a Memorandum of Understanding (“MOU”) with Way of Life Medical Cannabis to breed proprietary genetics, formulate, manufacture and distribute a wide range of Cannabis-based products to treat various medical conditions.
Yom Chai’s objective is to conduct scientific trials in Israel utilizing various Cannabinoid and Terpene profiles with the goal of realizing multiple successful discoveries (outcomes). Yom Chai’s goal is to bridge the gap between patients and doctors to bring scientifically proven products to market.
Scot Albert, COO of Yom Chai said, “We are excited to be working with Way of Life Medical Cannabis and Iris Vermouth, CEO to formulate, manufacture, and distribute world-class Cannabis based products to the international marketplace”.
Way of Life Medical Cannabis holds a license in Israel to cultivate Medical cannabis on Moshav Aviel and is a cooperative agricultural community of individual farms in the “Israel Toscana” area.